Clinitech Laboratory revenue climbs 15% to ₹9.49 crore in FY26
The diagnostic firm reported steady growth for the fiscal year, with net profit rising 7% as tax expenses weighed on the bottom line.
— 1 earlier story on Clinitech Laboratory Ltd. →What's new
- Revenue grew 15% to ₹9.49 crore for the fiscal year ended March 31, 2026.
- Consolidated net profit rose 7%, held back by higher tax expenses.
- The company has deployed ₹5.28 crore of its ₹5.78 crore IPO proceeds into diagnostic expansion.
Why this matters
For a nano-cap entity, these results show consistent, if modest, operational progress following its market debut. The successful allocation of nearly all IPO funds toward core diagnostic expansion provides a clear view of where the capital is going.
What we're watching
- Whether the company can improve net profit margins in FY27.
- Further updates on the diagnostic business expansion.
- The impact of tax expenses on future quarterly earnings.
The full read
Clinitech Laboratory posted a 15% revenue increase to ₹9.49 crore for the fiscal year ended March 31, 2026. Growth was steady.
While operating profits showed improvement, consolidated net profit growth was limited to 7% because higher tax expenses tempered the gains. The filing confirms that the company has successfully deployed ₹5.28 crore of its ₹5.78 crore IPO proceeds, focusing those funds on expanding its diagnostic business. For a nano-cap company, these figures indicate steady, predictable operations in the period following its listing. The results offer no major surprises, reflecting a standard year of growth and capital deployment.
Questions answered
- How did Clinitech Laboratory perform in FY26?
- The company recorded a 15% increase in revenue to ₹9.49 crore. Net profit growth was more modest at 7%, largely due to increased tax obligations.
- What is the status of the company's IPO proceeds?
- Clinitech has utilized ₹5.28 crore of the ₹5.78 crore raised in its IPO. The funds were primarily allocated to expanding its diagnostic operations.
- Are these results audited?
- Yes, the company released both standalone and consolidated financial results for the year ended March 31, 2026, accompanied by a statutory auditor certificate.
Story so far
All notes on CTLLAB →- 28 May 2026 · 3:09 PM IST Clinitech Laboratory revenue climbs 15% to ₹9.49 crore in FY26
- today Clinitech Laboratory revenue grows 15% in FY26